Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.
about
Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.Wound repair: role of immune-epithelial interactionsRemodeling of lipid bodies by docosahexaenoic acid in activated microglial cellsRecent insights into the cellular biology of atherosclerosisResolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance.Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseTreatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin SensitivityPro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi.Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.Macrophage Phenotype and Function in Different Stages of Atherosclerosis.MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.Calcium signalling and ER stress in insulin resistance and atherosclerosis.Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages.Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans.Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.Cell Death Inducing Microbial Protein Phosphatase Inhibitors--Mechanisms of Action.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.Specialized pro-resolving mediators in cardiovascular diseases.Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes.Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.Activation of autophagy in macrophages by pro-resolving lipid mediators.Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats.Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screeningMerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.Pro-Resolving Mediators in Regulating and Conferring Macrophage Function.Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.Immunoresolvents signaling molecules at intersection between the brain and immune system.CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function.Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite ControlSpecialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
P2860
Q24318444-E63904D5-8CA6-415A-A8FD-43819E7B5CF8Q26801818-24D3939C-ED94-40D4-88CF-5C60CC76B93BQ28395128-D607344C-1949-4726-9C3E-82365965BA64Q30300194-6AC1CCFF-D75B-412F-AC52-1DDE2B7B7382Q34508024-56A9EBA7-969B-48B9-AC42-D781F706B791Q35744344-45F08C3D-74EA-4841-A59F-69654FC0BA5FQ36095550-C8B6612F-5017-443C-A6D8-F73807490D6FQ36104668-80E6DF70-6BB8-4592-A10E-E4B52FC732FAQ36217771-A9CF3F37-8CF2-47A5-854F-09251DAAD035Q36330155-AF97932D-7260-4840-9F60-3E6728DCDB9FQ36602809-DFF1DB03-ECFA-4290-B7A5-81B2A4A313B5Q37183630-6E12A78D-6965-4228-8F04-0101CF48AC8DQ37282266-630DB6F9-9DEA-4A04-AF29-CF02CDC196D3Q37373729-32028D15-3667-483B-9870-4168CE0E71D3Q37379884-4A5219DE-73F3-4D29-A36E-25D0CDB3718CQ37545061-41DFEB5A-8420-4114-B081-F99F16F15F70Q37603197-E368F427-3B75-4EB2-9D4C-BD326AE8110FQ38617357-2A0D7827-FB42-497D-B018-FDE99D703A5AQ38681468-AB83060B-485D-48F8-AC8E-2BB6BC67E03EQ39160278-A25F9335-F969-4630-9586-EE4C89292849Q39385937-BB1896DB-49EC-49C3-AA8D-261C5188ECECQ39649085-8CF43630-B249-4E93-952B-B1B87DFB0CBDQ39961845-400AFD59-B3E4-4A30-91D0-EF9BED45D66FQ41222249-F7AC00DC-B4D8-4FC2-AD68-79DB4C0EF8ABQ41821577-5FB4D2DD-3ABC-4E45-BD38-8DD3AEA41674Q42001768-05017133-57E2-4C8D-8390-08B7D68EDCE8Q47104000-0487C508-0B4F-417D-A988-02A422710505Q47215351-FDB526E6-C4DC-454F-9F1D-7EF729217583Q47229251-BE4B6BA0-70C4-439F-8F4B-6AD7EC7980BEQ47708298-4D954498-726D-4ADB-8EE7-2FD2CE8118B5Q47744316-D9CB4E7A-F1F4-440E-B9AE-E3929D1F6AD6Q48507796-ADB6F1C5-0A0A-4A24-925A-546AEDB02DA3Q50233477-1127C323-6AFA-43E5-9ACA-BA1317784F20Q55514888-AFD517BA-2F9C-49BD-B620-3E94C99BFCDDQ58728070-3AE405DD-FEA0-482A-B017-7732EABD4E53Q59133957-5A19D0B4-0E8A-4D22-BCFE-CF7FCA3F6944
P2860
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@ast
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@en
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@nl
type
label
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@ast
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@en
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@nl
prefLabel
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@ast
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@en
Resolvin D1 limits 5-lipoxygen ...... cium-activated kinase pathway.
@nl
P2093
P2860
P356
P1476
Resolvin D1 limits 5-lipoxygen ...... lcium-activated kinase pathway
@en
P2093
Gabrielle Fredman
Jason Hellmann
Johannes Backs
Matthew Spite
Stefano Spolitu
P2860
P304
14530-14535
P356
10.1073/PNAS.1410851111
P407
P50
P577
2014-09-22T00:00:00Z